China National Accord Medicines Corp Ltd (SZSE:000028) Share Price

Company Profile

Business description
China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.
Contact
No. 15, Ba Gua Si 4th Road
Accord Pharmaceutical Building
Futian District
Guangdong Province
Shenzhen518029
CHN
T: +86 75525875140
http://www.szaccord.com.cn
Sector
Healthcare
Stock type
Defensive
Industry
Medical Distribution
Fiscal Year End
31 December 2026
Employees
28,336

Recommended

Microsoft’s earnings report is expected to touch on AI adoption and monetization.

Dan Romanoff, CPA | 23 April 2026

The ongoing war is likely to keep commodity prices even more volatile than usual until it is resolved.

Jon Mills, CFA | 23 April 2026

How investors can uncover value beyond the index heavyweights.

Tyger Fitzpatrick | 23 April 2026

Index	Last price	Change	% Change
All Ordinaries	9,024.20	27.20	-0.30%
CAC 40	8,198.69	42.26	0.52%
DAX 40	24,146.90	48.00	-0.20%
Dow JONES (US)	49,490.03	340.65	0.69%
FTSE 100	10,436.52	39.94	-0.38%
HKSE	25,905.77	257.47	-0.98%
NASDAQ	24,657.57	397.60	1.64%
Nikkei 225	59,140.23	445.63	-0.75%
NZX 50 Index	12,884.93	60.67	-0.47%
S&P 500	7,137.90	73.89	1.05%
S&P/ASX 200	8,793.40	26.10	-0.30%
SSE Composite Index	4,093.25	13.01	-0.32%